Aclaris Therapeutics (ACRS) Change in Acquisitions & Divestments (2014 - 2026)

Aclaris Therapeutics' Change in Acquisitions & Divestments history runs 13 years deep, the most recent figure standing at $20.8 million for Q1 2026.

• In Q1 2026, Change in Acquisitions & Divestments fell 30.81% year-over-year to $20.8 million; the TTM figure through Mar 2026 stood at $79.8 million (down 19.53% YoY), while the FY2025 annual figure was $89.0 million, up 3.36% from the prior year.
• Change in Acquisitions & Divestments was $20.8 million for Q1 2026 at Aclaris Therapeutics, up from $15.0 million in the prior quarter.
• In the past five years, Change in Acquisitions & Divestments ranged from a high of $70.6 million in Q2 2023 to a low of $8.0 million in Q4 2023.
• Historically, Change in Acquisitions & Divestments has averaged $32.8 million across 5 years, with a median of $30.0 million in 2025.
• The sharpest annual moves came in 2022 and 2023: Change in Acquisitions & Divestments jumped 325.28% in 2022, then tumbled 83.64% in 2023.
• A 5-year view of Change in Acquisitions & Divestments shows it stood at $48.8 million in 2022, then sank by 83.64% to $8.0 million in 2023, then surged by 119.17% to $17.5 million in 2024, then decreased by 14.35% to $15.0 million in 2025, then soared by 38.32% to $20.8 million in 2026.
• The last three Change in Acquisitions & Divestments figures came in at $20.8 million (Q1 2026), $15.0 million (Q4 2025), and $19.1 million (Q3 2025), per Business Quant data.